Elementis : Amendment to segmental reporting

Elementis plc

Amendment to segmental reporting

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today advises of a minor amendment to central cost allocation across its segmental reporting for 2022. All reported Group figures are unchanged.

As set out in the Group 2022 full year reporting, $6.8m of stranded costs in relation to the Chromium business were allocated to central costs. Going forward, these costs will be allocated to our two segments, Personal Care and Performance Specialties. To help analysts, ahead of the 2023 interim results on the 27 July, the table below sets out the previous and new segmental reporting for 2022 half year and full year periods.

As a reminder the majority of stranded costs are expected to be phased out by the end of 2023.

		Reported			Re-stated
	H1 22	H2 22	FY 22	H1 22	H2 22	FY 22
Revenue ($m)
Personal Care	105.6	105.9	211.5	105.6	105.9	211.5
Performance Specialties	281.8	243.1	524.9	281.8	243.1	524.9
Talc	72.5	63.3	135.8	72.5	63.3	135.8
Coatings	209.3	179.8	389.1	209.3	179.8	389.1
Total	387.4	349.0	736.4	387.4	349.0	736.4
Adjusted Operating Profit ($m)
Personal Care	25.9	26.9	52.8	24.0	25.0	49.0
Performance Specialties	46.5	26.4	72.9	44.9	25.0	69.9
Talc	2.7	-3.1	-0.4	2.7	-3.1	-0.4
Coatings	43.8	29.5	73.3	42.2	28.1	70.3
Corporate Costs	-14.2	-11.0	-25.2	-10.7	-7.7	-18.4
Total	58.2	42.3	100.5	58.2	42.3	100.5

Note: All figures are un-audited except for reported FY 22.